About: The Outcome of COVID-19 Patients with Acute Myocardial Infarction

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The Outcome of COVID-19 Patients with Acute Myocardial Infarction Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The Outcome of COVID-19 Patients with Acute Myocardial Infarction
Creator	Ali, Mohamed Al Maslamani, Muna Chb, Omrani, Ali Al Kaabi, Saad Al Suwaidi, Jassim Al Tamimi, Hassan Al Tamimi, Omar Al-Hijji, Mohammed Al-Qahtani, Awad Albinali, Hajar Alhamad, Yasser Alkhal, Abdullatif Alkhani, Murad Alnesf, Mariam Arafa, Salaheddine Asaad, Nidal Chb, M Elhassan, Mowahib Elsousy, Reem Hamid, Tahir Jalala, Salem Khalil, Charbel Khazaal, Fadi Rafie, Ihsan Rahman Arabi, Abdul Soaly, Ezeldine
Source	MedRxiv
abstract	Background Coronavirus Disease 2019 (COVID-19) is a rapidly expanding global pandemic resulting in significant morbidity and mortality. COVID-19 patients may present with acute myocardial infarction (AMI). The aim of this study is to conduct detailed analysis on patients with AMI and COVID-19. Methods We included all patients admitted with AMI and actively known or found to be COVID-19 positive by PCR between the 4th February 2020 and the 11th June 2020 in the State of Qatar. Patients were divided into ST-elevation myocardial infarction (STEMI) and Non-STE (NSTEMI). Results There were 68 patients (67 men and 1 woman) admitted between the 4th of February 2020 and the 11th of June 2020 with AMI and COVID-19. The mean age was 49.1, 46 patients had STEMI and 22 had NSTEMI. 38% had diabetes mellitus, 31% had hypertension, 16% were smokers, 13% had dyslipidemia, and 14.7% had prior cardiovascular disease. Chest pain and dyspnea were the presenting symptoms in 90% and 12% of patients respectively. Fever (15%) and cough (15%) were the most common COVID-19 symptoms, while the majority had no viral symptoms. Thirty-nine (33 STEMI and 6 NSTEMI) patients underwent coronary angiography, 38 of them had significant coronary disease. Overall in-hospital MACE was low; 1 patient developed stroke and 2 died. Conclusion Contrary to previous small reports, overall in-hospital adverse events were low in this largest cohort of COVID-19 patients presenting with AMI. We hypothesize patient profile including younger age contributed to these findings. Further studies are required to confirm this observation.
has issue date	2020-07-27(xsd:dateTime)
bibo:doi	10.1101/2020.07.21.20156349
has license	medrxiv
sha1sum (hex)	5d4fd4b896b740de63624b0c4773350b4992ff61
schema:url	https://doi.org/10.1101/2020.07.21.20156349
resource representing a document's title	The Outcome of COVID-19 Patients with Acute Myocardial Infarction
resource representing a document's body	covid:5d4fd4b896b740de63624b0c4773350b4992ff61#body_text
is schema:about of	named entity 'pandemic' named entity 'COVID-19' named entity 'aim' named entity 'patients' named entity 'COVID-19' named entity 'COVID-19' named entity 'global pandemic' named entity 'AMI' named entity 'Acute Myocardial Infarction' named entity 'COVID-19' named entity 'smokers' named entity 'WHO' named entity 'medRxiv' named entity 'hypertension' named entity 'CC-BY-NC-ND 4.0' named entity 'Heart Hospital' named entity 'medRxiv' named entity 'STEMI' named entity 'STEMI' named entity 'left circumflex artery' named entity 'pacemaker' named entity 'chest pain' named entity 'COVID' named entity 'obstructive coronary artery disease' named entity 'ischemic' named entity 'preprint' named entity 'CAD' named entity 'evidence-base' named entity 'human body' named entity 'Lombardy' named entity 'COVID-19' named entity 'Heart Hospital' named entity 'myocardial infarction' named entity 'preprint' named entity 'medRxiv' named entity 'clinical presentation' named entity 'COVID-19' named entity 'preprint' named entity 'angiotensin converting enzyme 2' named entity 'CAD' named entity 'medRxiv' named entity 'mortality rate' named entity 'preprint' named entity 'preprint' named entity 'disease transmission' named entity 'preprint' named entity 'medRxiv' named entity 'Lombardy' named entity 'Risk factors' named entity 'antiplatelet therapy' named entity 'NSTEMI' named entity 'hemodialysis' named entity 'cardiogenic shock' named entity 'reperfusion' named entity 'preprint' named entity 'preprint' named entity 'COVID-19 pandemic' named entity 'low molecular weight heparin' named entity 'cardiovascular procedures'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software